Zydus Lifesciences informs about press release

16 Dec 2023 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated December 16, 2023 titled ‘Zydus receives final approval from the USFDA for Lacosamide Tablets’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

876.10 3.15 (0.36%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×